MEDICATION TRIALS Flashcards

1
Q

What is OMECAMTIV MECARBIL?

A

A myosin ATPase activator that enhances myosin crossbridge and reduces heart failure.

Known as omecamtiv-ator.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What was the focus of the PIONEER TRIAL?

A

To evaluate the effects of OMECAMTIV MECARBIL in heart failure.

This trial specifically assessed the drug’s efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is MAVACAMTEN?

A

A myosin inhibitor targeting excessive contractility and impaired relaxation.

It aims to improve NYHA and exercise capacity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does MAVACAMTEN improve?

A

NYHA classification and exercise capacity.

NYHA stands for New York Heart Association classification.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What was the focus of the GALACTIC HF trial?

A

To evaluate MAVACAMTEN in patients with heart failure.

This trial specifically assessed the drug’s efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is VERICIGUAT?

A

A guanylate cyclase stimulator that induces nitric oxide (NO).

It is used in the treatment of heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What was the focus of the VICTORIA TRIAL?

A

To evaluate the effects of VERICIGUAT in heart failure patients.

This trial highlighted the drug’s impact on heart failure management.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly